China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) has seen 11,564,154 shares traded in the recent trading session. The company, currently valued at $15.68 Million, closed the recent trade at $0.5651 per share which meant it lost $0 on the day or 5.9% during that session. The SXTC stock price is -784.8% off its 52-week high price of $5 and 39.83% above the 52-week low of $0.34. If we look at the company’s 10-day average daily trading volume, we find that it stood at 12.14 Million shares traded. The 3-month trading volume is 5.24 Million shares.
The consensus among analysts is that China SXT Pharmaceuticals, Inc. (SXTC) is a 0 stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 0 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) trade information
Sporting 7.33% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the SXTC stock price touched $0.59 or saw a rise of 4.14%. Year-to-date, China SXT Pharmaceuticals, Inc. shares have moved -31.02%, while the 5-day performance has seen it change 11.03%. Over the past 30 days, the shares of China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) have changed 42.97%. Short interest in the company has seen 103.61 Million shares shorted with days to cover at 19.77.
China SXT Pharmaceuticals, Inc. (SXTC) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +0% while over the next 5 years, the company’s earnings are expected to increase by 0%.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC)’s Major holders
Insiders own 51.21% of the company shares, while shares held by institutions stand at 15.24% with a share float percentage of 31.23%. Investors are also buoyed by the number of investors in a company, with China SXT Pharmaceuticals, Inc. having a total of 7 institutions that hold shares in the company. The top two institutional holders are Hudson Bay Capital Management LP with over 2.15 Million shares worth more than $1.2 Million. As of March 30, 2020, Hudson Bay Capital Management LP held 7.75% of shares outstanding.
The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 598.74 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $335.35 Thousand and represent 2.16% of shares outstanding.